Gear Up for FMC Technologies (FTI) Q2 Earnings: Wall Street Estimates for Key Metrics

22.07.25 15:15 Uhr

Werte in diesem Artikel
Aktien

35,68 EUR -0,24 EUR -0,67%

45,72 EUR 0,07 EUR 0,15%

76,50 EUR -1,50 EUR -1,92%

27,50 EUR 0,11 EUR 0,40%

Indizes

PKT PKT

2.052,5 PKT -20,1 PKT -0,97%

2.120,7 PKT -23,6 PKT -1,10%

24.041,9 PKT -265,9 PKT -1,09%

9.007,1 PKT -99,6 PKT -1,09%

1.922,8 PKT -17,1 PKT -0,88%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

201,2 PKT -0,5 PKT -0,26%

562,7 PKT -4,0 PKT -0,70%

12.614,9 PKT -133,6 PKT -1,05%

24.063,0 PKT -181,0 PKT -0,75%

24.058,5 PKT -212,4 PKT -0,88%

9.313,2 PKT -99,0 PKT -1,05%

17.157,6 PKT -92,0 PKT -0,53%

1.854,4 PKT -8,4 PKT -0,45%

Wall Street analysts expect FMC Technologies (FTI) to post quarterly earnings of $0.57 per share in its upcoming report, which indicates a year-over-year increase of 32.6%. Revenues are expected to be $2.49 billion, up 6.9% from the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 0.4% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.With that in mind, let's delve into the average projections of some FMC Technologies metrics that are commonly tracked and projected by analysts on Wall Street.Analysts predict that the 'Revenue- Surface Technologies' will reach $313.91 million. The estimate points to a change of -0.8% from the year-ago quarter.According to the collective judgment of analysts, 'Revenue- Subsea Technologies' should come in at $2.17 billion. The estimate indicates a year-over-year change of +8%.Based on the collective assessment of analysts, 'Revenue- Lease' should arrive at $64.65 million. The estimate indicates a year-over-year change of +8.3%.The combined assessment of analysts suggests that 'Revenue- Product' will likely reach $885.48 million. The estimate points to a change of +2.9% from the year-ago quarter.The consensus estimate for 'Revenue- Service' stands at $1.53 billion. The estimate suggests a change of +9.1% year over year.Analysts expect 'Inbound Orders - Subsea Technologies' to come in at $2.49 billion. The estimate compares to the year-ago value of $2.84 billion.Analysts' assessment points toward 'Order Backlog - Subsea Technologies' reaching $15.25 billion. The estimate compares to the year-ago value of $12.93 billion.It is projected by analysts that the 'Order Backlog - Total' will reach $16.10 billion. Compared to the current estimate, the company reported $13.90 billion in the same quarter of the previous year.Analysts forecast 'Order Backlog - Surface Technologies' to reach $870.52 million. The estimate is in contrast to the year-ago figure of $972.90 million.The average prediction of analysts places 'Inbound Orders - Surface Technologies' at $287.21 million. The estimate is in contrast to the year-ago figure of $254.20 million.The collective assessment of analysts points to an estimated 'Inbound Orders - Total' of $2.76 billion. The estimate is in contrast to the year-ago figure of $3.09 billion.The consensus among analysts is that 'Adjusted EBITDA- Subsea' will reach $452.54 million. The estimate compares to the year-ago value of $356.50 million. View all Key Company Metrics for FMC Technologies here>>> Shares of FMC Technologies have experienced a change of -5.7% in the past month compared to the +5.9% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), FTI is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report TechnipFMC plc (FTI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf FMC

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Wer­bung

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
21.07.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
21.07.2025Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
21.07.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
14.07.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
27.06.2025Fresenius Medical Care (FMC) St NeutralUBS AG
DatumRatingAnalyst
14.07.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
23.06.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
18.06.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
21.05.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
12.05.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
DatumRatingAnalyst
21.07.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
18.06.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
18.06.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
17.06.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
06.06.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen